<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cmt2d" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cmt2d</book-part-id>
      <title-group>
        <title><italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Goldfarb</surname>
            <given-names>Lev G</given-names>
          </name>
          <xref ref-type="aff" rid="cmt2d.AFF1"/>
          <degrees>MD</degrees>
          <email>goldfarbl@ninds.nih.gov</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Sivakumar</surname>
            <given-names>Kumaraswamy</given-names>
          </name>
          <xref ref-type="aff" rid="cmt2d.AFF2"/>
          <degrees>MD</degrees>
          <email>ksivakumar@azneuromuscular.org</email>
        </contrib>
      </contrib-group>
      <aff id="cmt2d.AFF1">Clinical Neurogenetics Unit <break/>National Institute of Neurological Disorders and Stroke <break/>National Institutes of Health <break/>Bethesda, Maryland </aff>
      <aff id="cmt2d.AFF2">Neuromuscular Research Center <break/>Barrow Neurological Institute <break/>St Joseph's Hospital and Medical Center <break/>Phoenix, Arizona </aff>
      <pub-history>
        <date iso-8601-date="2006-11-08" date-type="created">
          <day>08</day>
          <month>11</month>
          <year>2006</year>
        </date>
        <date iso-8601-date="2011-08-25" date-type="updated">
          <day>25</day>
          <month>08</month>
          <year>2011</year>
        </date>
        <date iso-8601-date="2007-01-30" date-type="revised">
          <day>30</day>
          <month>01</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="g6pc3-def" document-type="chapter">G6PC3 Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="gata1" document-type="chapter"><italic toggle="yes">GATA1</italic>-Related X-Linked Cytopenia</related-object>
      <abstract id="cmt2d.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">GARS</italic>-associated axonal neuropathy (Charcot-Marie-Tooth neuropathy type 2D/distal spinal muscular atrophy V [CMT2D/dSMA-V]) is characterized by adolescent or early-adult onset of bilateral weakness and atrophy of thenar and first dorsal interosseus muscles, sparing of the hypothenar eminence until later in the course of illness, and mild to moderate impairment of vibration sense in the hands and feet later in the disease course in a minority of individuals. The phenotype is considered the CMT2D subtype when sensory deficits (reduction of pinprick, temperature, touch, and vibration perception in a stocking and [less often] glove pattern) are present and dSMA-V when sensory deficits are absent. The lower limbs are involved in about half of affected individuals. The earliest elicited manifestations in many individuals are transient cramping and pain in the hands on exposure to cold and cramping in calf muscles on exertion. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">GARS</italic>-associated axonal neuropathy is based on clinical findings, electromyography (EMG), and molecular genetic testing of <italic toggle="yes">GARS,</italic> encoding glycyl-tRNA synthetase. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Assistive devices for weak hands, ankle support, toe-up braces, ankle-foot orthotics as necessary. </p>
          <p><italic toggle="yes">Surveillance</italic>: Periodic assessment by a neurologist and/or neuromuscular disorders specialist to asses progression of weakness in the limbs and determine the need for prosthetic or assistive devices. </p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">GARS</italic>-associated axonal neuropathy is inherited in an autosomal dominant manner. Most individuals diagnosed with the disorder have an affected parent. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutations is unknown. Each child of an individual with <italic toggle="yes">GARS</italic>-associated axonal neuropathy has a 50% chance of inheriting the mutation. Prenatal testing is possible if the disease-causing mutation has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cmt2d.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="cmt2d.T.nc_garsassociated_axonal_neuropa" position="anchor" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <th id="hd_b_cmt2d.T.nc_garsassociated_axonal_neuropa_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy: Included Disorders</th>
              </tr>
              <tr>
                <td headers="hd_b_cmt2d.T.nc_garsassociated_axonal_neuropa_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Charcot-Marie-Tooth neuropathy type 2D (CMT2D)</p>
                    </list-item>
                    <list-item>
                      <p>Distal spinal muscular atrophy V (dSMA-V)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="cmt2d.TF.1">
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="cmt2d.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="cmt2d.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cmt2d.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p><italic toggle="yes">GARS</italic>-associated axonal neuropathy (Charcot-Marie-Tooth neuropathy type 2D/distal spinal muscular atrophy V [CMT2D/dSMA-V]) is characterized by the following: </p>
          <list list-type="bullet">
            <list-item>
              <p>Adolescent or early-adult onset of bilateral weakness and atrophy of thenar and first dorsal interosseus muscles. The disease progresses to involve hypothenar, foot, and peroneal muscles in most (not all) individuals. </p>
            </list-item>
            <list-item>
              <p>Mild to moderate impairment of vibration sense developing in advanced illness in a minority of individuals </p>
            </list-item>
            <list-item>
              <p>Chronic denervation on EMG in distal muscles with reduced compound motor action potentials at near-normal or normal motor conduction velocities and preserved sensory nerve action potentials (SNAPs), including the sural response. See <bold>Electrophysiologic studies</bold>. </p>
            </list-item>
            <list-item>
              <p>Mild to moderate selective loss of small- and medium-size myelinated and small unmyelinated axons on sural nerve biopsy. See <xref ref-type="table" rid="cmt2d.T.phenotypic_features_of_garsassoc">Nerve biopsy</xref>. </p>
            </list-item>
            <list-item>
              <p>CMT2D phenotype only: presence of sensory deficits including reduction of pinprick, temperature, touch, and vibration perception in a stocking and (less often) glove pattern </p>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal dominant inheritance </p>
            </list-item>
          </list>
          <p><bold>Electrophysiologic studies</bold> are consistent with motor axonopathy. A demyelinating neuropathy is not associated with this entity (<xref ref-type="table" rid="cmt2d.T.results_of_electrophysiologic_st">Table 1</xref>). EMG shows denervation predominantly in the distal muscle groups at normal motor distal latencies and conduction velocities: </p>
          <list list-type="bullet">
            <list-item>
              <p>Absent or markedly reduced (frequently &#x0003c;1 mV) compound muscle action potentials (CMAPs) are recorded from the abductor pollicis brevis (APB) by median nerve stimulation [<xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</xref>]. </p>
            </list-item>
            <list-item>
              <p>Preserved CMAPs are recorded from the abductor digiti minimi (ADM) by ulnar nerve stimulation. </p>
            </list-item>
            <list-item>
              <p>CMAP amplitude recorded by stimulation of the peroneal nerve is below 2 mV in most individuals and below 1 mV in individuals having clinically evident leg atrophy. </p>
            </list-item>
            <list-item>
              <p>Normal median SNAP amplitudes and conduction velocities are seen in most individuals, even those with mildly prolonged distal motor latency. </p>
            </list-item>
            <list-item>
              <p>In individuals with advanced disease, needle EMG shows no voluntary motor activity in the abductor pollicis and first dorsal interossei because of marked atrophy. Spontaneous activity is often seen in these muscles. </p>
            </list-item>
            <list-item>
              <p>The elicited sural SNAPs are preserved but with a reduced amplitude, despite sensory axonal loss identified histopathologically on examination of a sensory nerve from an individual with the CMT2D subtype; similar but milder changes were seen in individuals with dSMA-V. </p>
            </list-item>
          </list>
          <table-wrap id="cmt2d.T.results_of_electrophysiologic_st" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Results of Electrophysiologic Studies in <italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy Subtypes</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" colspan="2" align="left" valign="middle" rowspan="2" headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1">Results of Electrophysiologic Studies</th>
                  <th id="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2" colspan="2" align="left" valign="middle" rowspan="1">Subtype</th>
                </tr>
                <tr>
                  <th headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2" id="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">CMT2D (%)</th>
                  <th headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2" id="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">dSMA-V (%)</th>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="12" colspan="1">
                    <bold>Motor Nerve Conduction</bold>
                  </td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" colspan="3" align="left" valign="middle" rowspan="1">
                    <bold>Compound muscle action potential</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Median-APB &#x0003c;4.5 mV</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Ulnar-ADM &#x0003c;3.5 mV</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Peroneal-EDB &#x0003c;2 mV</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">62.5</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Tibial-AH &#x0003c;2.5 mV</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">50</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" colspan="3" align="left" valign="middle" rowspan="1">
                    <bold>Distal motor latency</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Median &#x0003c;5.6 ms</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Ulnar &#x0003c;4.5 ms</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">11</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Peroneal &#x00026; tibial &#x0003c;7.5 ms</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" colspan="3" align="left" valign="middle" rowspan="1">
                    <bold>Nerve conduction velocity</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Median &#x00026; ulnar &#x0003c;39 m/s</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Peroneal &#x00026; tibial &#x0003c;29 m/s</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                    <bold>Sensory Nerve Conduction</bold>
                  </td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" colspan="3" align="left" valign="middle" rowspan="1">
                    <bold>Sensory nerve action potential</bold>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Median &#x0003c;10 &#x000b5;V; ulnar &#x0003c;8 &#x000b5;V</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">12</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Sural &#x0003c;6 &#x000b5;V</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">17</td>
                  <td headers="hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_1_2 hd_b_cmt2d.T.results_of_electrophysiologic_st_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">29</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cmt2d.TF.2">
                <p>APB = Abductor pollicis brevis </p>
              </fn>
              <fn id="cmt2d.TF.2.1">
                <p>ADM = Abductor digiti minimi </p>
              </fn>
              <fn id="cmt2d.TF.2.2">
                <p>EDB = Extensor digitorum brevis </p>
              </fn>
              <fn id="cmt2d.TF.2.3">
                <p>AH = Adductor hallucis</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Nerve biopsy.</bold> The dSMA-V subtype shows clear signs of axonal pathology with two or more regenerative clusters per fascicle (<xref ref-type="fig" rid="cmt2d.F1">Figure 1A</xref>). No evidence of active degeneration and no obvious signs of demyelination or typical onion bulb formation are present. Myelin structures appear normal. Overall myelinated fiber density is normal (<xref ref-type="fig" rid="cmt2d.F1">Figure 1B</xref>). Fibers less than 7 mm in diameter represent 52% of the overall number of fibers in the affected individual compared to 65% in control specimens. Electron microscopy (EM) shows denervated Schwann cell subunits as indicated by an increased number of profiles, suggesting damage to small unmyelinated nerve fibers (UMNFs) (<xref ref-type="fig" rid="cmt2d.F1">Figure 1C</xref>). The UMNF density is at the low normal level. </p>
          <p>The CMT2D subtype shows clear evidence of axonal pathology in nerve biopsy in one individual. Axonal swelling with filamentous accumulations (<xref ref-type="fig" rid="cmt2d.F1">Figure 1D</xref>) and four to eight regenerative clusters per fascicle are observed (<xref ref-type="fig" rid="cmt2d.F1">Figure 1E</xref>). Pseudo onion bulb formations and a few thinly myelinated fibers are seen. Myelin structures appear intact. Overall myelinated fiber density is reduced. The proportion of fibers less than 7 mm in diameter is only 46%. Denervation of Schwann cell subunits as indicated by an increased number of profiles is seen on EM. </p>
        </sec>
        <sec id="cmt2d.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">GARS</italic>-associated axonal neuropathy is caused by mutations in <italic toggle="yes">GARS</italic>, the gene encoding glycyl-tRNA synthetase. </p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="cmt2d.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                    <italic toggle="yes">GARS</italic>
                  </td>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion / duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Exonic or whole-gene deletions / duplications</td>
                  <td headers="hd_b_cmt2d.T.summary_of_molecular_genetic_tes_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown; none reported&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cmt2d.TF.3">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="cmt2d" object-id="cmt2d.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. </p>
              </fn>
              <fn id="cmt2d.TF.3.1">
                <label>2.</label>
                <p>See <xref ref-type="sec" rid="cmt2d.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
              </fn>
              <fn id="cmt2d.TF.3.2">
                <label>3.</label>
                <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
              </fn>
              <fn id="cmt2d.TF.3.3">
                <label>4.</label>
                <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>. </p>
              </fn>
              <fn id="cmt2d.TF.3.4">
                <label>5.</label>
                <p>Sequence analysis of <italic toggle="yes">GARS</italic> detects all known pathogenic mutations.</p>
              </fn>
              <fn id="cmt2d.TF.3.5">
                <label>6.</label>
                <p>Testing that identifies exonic or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="cmt2d.TF.3.6">
                <label>7.</label>
                <p>No deletions or duplications of <italic toggle="yes">GARS</italic> have been reported to cause <italic toggle="yes">GARS</italic>-associated axonal neuropathy. Therefore, the usefulness of this testing is unknown.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="cmt2d.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirming/establishing the diagnosis in a proband.</bold> A preliminary diagnosis can be made based on clinical data and electrophysiologic findings (i.e., EMG); confirmation of the diagnosis requires molecular genetic testing of <italic toggle="yes">GARS</italic>. Note: EMG is more widely available than nerve biopsy, which can be used in a single individual in a family or in diagnostically difficult cases.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="cmt2d.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="cmt2d.Natural_History">
          <title>Clinical Description</title>
          <p>CMT2D (distal motor and sensory neuropathy) [<xref ref-type="bibr" rid="cmt2d.REF.ionasescu.1996.1373">Ionasescu et al 1996</xref>] and dSMA-V (exclusively motor distal involvement) [<xref ref-type="bibr" rid="cmt2d.REF.christodoulou.1995.1629">Christodoulou et al 1995</xref>] were originally thought to be distinct entities, but family studies [<xref ref-type="bibr" rid="cmt2d.REF.sambuughin.1998.23">Sambuughin et al 1998</xref>, <xref ref-type="bibr" rid="cmt2d.REF.ellsworth.1999.568">Ellsworth et al 1999</xref>] and later molecular genetic studies [<xref ref-type="bibr" rid="cmt2d.REF.antonellis.2003.1293">Antonellis et al 2003</xref>, <xref ref-type="bibr" rid="cmt2d.REF.delbo.2006.752">Del Bo et al 2006</xref>] determined that they are allelic. In this <italic toggle="yes">GeneReview</italic> the term <italic toggle="yes">GARS</italic>-associated axonal neuropathy includes these two allelic disorders.</p>
          <p>Both disease subtypes, CMT2D and dSMA-V, are characterized by adolescent or early-adult onset of unique patterns of motor and sensory manifestations. The hallmark is the onset of weakness and atrophy in the thenar and the first dorsal interosseus muscles and the sparing of the hypothenar eminence until later in the course of illness. The lower limbs are involved in about half of affected individuals; mild loss of vibration sense is observed in a third of individuals in advanced disease. </p>
          <p>The presenting symptom is muscle weakness in the hands occurring between age eight and 36 years, with most individuals (75%) developing symptoms during the second decade of life [<xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</xref>]. The earliest elicited manifestations of illness in many individuals are transient cramping and pain in the hands on exposure to cold and cramping in calf muscles on exertion. Progressive weakness and atrophy of the thenar and first dorsal interossei muscles are the major complaints in affected individuals (<xref ref-type="fig" rid="cmt2d.F2">Figure 2</xref>, <xref ref-type="table" rid="cmt2d.T.phenotypic_features_of_garsassoc">Table 3</xref>) </p>
          <p>Lower extremity involvement, when present, varies in severity from weakness and atrophy of the extensor digitorum brevis (EDB) and weakness of toe dorsiflexors to classic peroneal muscular atrophy with foot drop. Peroneal muscles are affected earlier and more severely than the calf muscles. If peroneal muscular atrophy develops, it is associated with <italic toggle="yes">pes cavus</italic> and moderate sensory abnormalities in stocking distribution and (less often) glove distribution. Individuals with lower leg involvement have a high steppage gait. </p>
          <p>Proximal limb muscle weakness is not observed in the upper or lower extremities. </p>
          <p>Sensory examination is either normal or shows mild to moderate impairment of vibration sense in the hands and feet; in individuals with the CMT2D subtype, reduction of pinprick, temperature, touch, and vibration perception in a stocking and (less often) glove pattern is observed (<xref ref-type="table" rid="cmt2d.T.phenotypic_features_of_garsassoc">Table 3</xref>). </p>
          <p>Reflexes at the ankles are diminished or absent in individuals with leg muscle weakness and sensory deficits. </p>
          <table-wrap id="cmt2d.T.phenotypic_features_of_garsassoc" position="anchor" orientation="portrait">
            <label>Table 3.</label>
            <caption>
              <p>Phenotypic Features of <italic toggle="yes">GARS</italic>-Associated Axonal Neuropathy Subtypes</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1" headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1">Symptoms and Signs</th>
                  <th id="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2" colspan="2" align="left" valign="middle" rowspan="1">Subtype</th>
                </tr>
                <tr>
                  <th headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2" id="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">CMT2D (%)</th>
                  <th headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2" id="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">dSMA-V (%)</th>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Progressive bilateral weakness and wasting of thenar and FDI muscles&#x000a0;<sup>1</sup>
</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Peroneal weakness with atrophy and <italic toggle="yes">pes cavus</italic>
</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">57.5</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Pyramidal dysfunction</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">12.5</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Reduced sensation for touch, pain, and temperature</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Reduced vibration sense</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">100</td>
                  <td headers="hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_1_2 hd_b_cmt2d.T.phenotypic_features_of_garsassoc_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">37.5</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cmt2d.TF.4">
                <p><xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al [2005]</xref>
</p>
              </fn>
              <fn id="cmt2d.TF.4.1">
                <p>1.&#x000a0;FDI = First dorsal interosseus</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="cmt2d.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The <italic toggle="yes">GARS</italic> variants p.Lys129Pro and p.His418Arg are exclusively associated with the dSMA-V clinical subtype; p.Gly240Arg, p.Ile280Phe, and p.Gly526Arg are associated with the CMT2D subtype. The variants p.Glu71Gly, p.Pro244Lys, and p.Asp500Asn are identified in families with both subtypes.</p>
        </sec>
        <sec id="cmt2d.Penetrance">
          <title>Penetrance</title>
          <p><italic toggle="yes">GARS</italic> variants p.Lys129Pro and p.His418Arg are incompletely penetrant; however, data regarding the actual penetrance are limited.</p>
        </sec>
        <sec id="cmt2d.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is not observed.</p>
        </sec>
        <sec id="cmt2d.Nomenclature">
          <title>Nomenclature</title>
          <p>The term <italic toggle="yes">GARS</italic>-associated axonal neuropathy includes an axonal form of CMT type 2 and a similar group of clinical syndromes classified as distal hereditary motor neuropathy or distal spinal muscular atrophy (dSMA-V). <italic toggle="yes">GARS</italic>-associated axonal neuropathy is considered the CMT2D subtype when sensory deficits (reduction of pinprick, temperature, touch, and vibration perception in a stocking and [less often] glove pattern) are present and dSMA-V when sensation is normal or a sensory response is present on nerve conduction studies. </p>
        </sec>
        <sec id="cmt2d.Prevalence">
          <title>Prevalence</title>
          <p>Disease prevalence is unknown and is likely very rare. Within the past eight years, only a dozen families with <italic toggle="yes">GARS</italic>-associated axonal neuropathy have been identified worldwide [<xref ref-type="bibr" rid="cmt2d.REF.motley.2010.59">Motley et al 2010</xref>]. </p>
        </sec>
      </sec>
      <sec id="cmt2d.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are associated with mutations in <italic toggle="yes">GARS</italic>. </p>
      </sec>
      <sec id="cmt2d.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>GARS-associated axonal neuropathy needs to be distinguished from other forms of CMT, spinal muscular atrophy (SMA), and unrelated but similar neurologic conditions.</p>
        <p>Other subtypes of <related-object link-type="booklink" source-id="gene" document-id="cmt2" document-type="chapter"><bold>Charcot-Marie-Tooth disease type 2</bold></related-object>
<bold>(CMT2)</bold> have a wide range of onset age and diverse manifestations. Generally, individuals with CMT2 present with distal muscular atrophy, loss of reflexes, sensory deficits, reduced sensory nerve action potentials (SNAPs), and normal or mildly slowed motor nerve conduction velocity. The unique pattern of hand involvement before leg involvement and preserved SNAPs helps distinguish CMT2D from other CMT2 subtypes. </p>
        <p>Other types of <bold>distal spinal muscular atrophy (dSMA),</bold> a genetically heterogeneous group of disorders caused by progressive degeneration of anterior horn neurons, is characterized by slowly progressive muscle weakness and atrophy in the distal limbs without sensory deficits. SNAPs are preserved and motor conduction velocities are nearly normal. A separate set of genes in which mutation is disease-causing have been associated with dSMA subtypes [<xref ref-type="bibr" rid="cmt2d.REF.irobi.2004a.R195">Irobi et al 2004a</xref>, <xref ref-type="bibr" rid="cmt2d.REF.irobi.2004c.597">Irobi et al 2004c</xref>]. The pattern of hand involvement before leg involvement distinguishes dSMA-V from other dSMA subtypes. A dSMA-V variant associated with spasticity in the legs and amyotrophy in the hands is known as Silver syndrome [<xref ref-type="bibr" rid="cmt2d.REF.silver.1966.69">Silver 1966</xref>]. Caused by mutations in <italic toggle="yes">BSCL2</italic>, encoding seipin [<xref ref-type="bibr" rid="cmt2d.REF.irobi.2004b.2124">Irobi et al 2004b</xref>, <xref ref-type="bibr" rid="cmt2d.REF.windpassinger.2004.271">Windpassinger et al 2004</xref>], Silver syndrome is now known to be part of the spectrum of the <related-object link-type="booklink" source-id="gene" document-id="spg17" document-type="chapter"><italic toggle="yes">BSCL2</italic>-related neurologic disorders</related-object>. In contrast to Silver syndrome, in which most individuals have spasticity, only a minority of individuals with <italic toggle="yes">GARS</italic>-associated axonal neuropathy show mild pyramidal signs and spasticity (<xref ref-type="table" rid="cmt2d.T.phenotypic_features_of_garsassoc">Table 3</xref>) [<xref ref-type="bibr" rid="cmt2d.REF.christodoulou.1995.1629">Christodoulou et al 1995</xref>, <xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</xref>, <xref ref-type="bibr" rid="cmt2d.REF.dubourg.2006.1721">Dubourg et al 2006</xref>]. </p>
        <p><bold>Other neurologic disorders.</bold> The clinical pattern of disease onset with hand weakness and atrophy rather than foot involvement and absent sensory deficits in the early stages of the illness should raise a suspicion of carpal tunnel syndrome, neurogenic thoracic outlet syndrome, or multifocal motor neuropathy: </p>
        <list list-type="bullet">
          <list-item>
            <p>In the absence of family history, paresthesia, and pain, the clinical pattern of median nerve dysfunction at the wrist in individuals with carpal tunnel syndrome may be similar to that seen in the early stages of <italic toggle="yes">GARS</italic>-associated axonal neuropathy. Carpal tunnel syndrome is usually asymmetric and limited to median nerve. </p>
          </list-item>
          <list-item>
            <p>Compression of the lower cervical and T1 roots caused by a cervical rib may result in neurogenic thoracic outlet syndrome. In this condition, thenar, hypothenar and interossei weakness/atrophy is associated with ulnar and medial antebrachial cutaneous hypesthesia that could be validated by nerve conduction studies that show reduced SNAP amplitudes in the medial antebrachial cutaneous and ulnar nerves. </p>
          </list-item>
          <list-item>
            <p>Multifocal motor neuropathy is a sporadic autoimmune demyelinating disease causing slowly progressing motor disturbances in peripheral nerve distributions, predominantly in the distal upper extremities. It is often asymmetric and eventually involves hand muscles innervated by two or more motor nerves. Electrophysiologic conduction block can be demonstrated in the motor nerves and anti GM1 antibody titers are often elevated. </p>
          </list-item>
        </list>
      </sec>
      <sec id="cmt2d.Management">
        <title>Management</title>
        <sec id="cmt2d.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the diagnosis and extent of disease in an individual diagnosed with <italic toggle="yes">GARS</italic>-associated axonal neuropathy, nerve conduction studies and EMG of arms and legs are recommended.</p>
        </sec>
        <sec id="cmt2d.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Appropriate treatment includes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Prosthetic and adaptive devices for weak hands. Numerous devices are available for various activities of daily living.</p>
            </list-item>
            <list-item>
              <p>Ankle support, toe-up braces, and ankle-foot orthotics, as necessary to improve gait.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt2d.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications </title>
          <p>Stretching exercises, finger splints, and ankle braces to prevent contractures and deformities are appropriate.</p>
        </sec>
        <sec id="cmt2d.Surveillance">
          <title>Surveillance</title>
          <p>Surveillance includes periodic assessment by a neurologist and/or a neuromuscular disorders specialist to assess progression of weakness in the limbs and determine the need for use of prosthetic and assistive devices.</p>
        </sec>
        <sec id="cmt2d.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid </title>
          <p>Avoid neurotoxic agents (chemotherapy that may cause peripheral nerve injury).</p>
        </sec>
        <sec id="cmt2d.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk </title>
          <p>See <xref ref-type="sec" rid="cmt2d.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cmt2d.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="cmt2d.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cmt2d.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">GARS</italic>-associated axonal neuropathy is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="cmt2d.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with <italic toggle="yes">GARS</italic>-associated axonal neuropathy have an affected parent. The family history may appear to be negative because of failure to recognize the disorder in family members, early death of a parent before the onset of symptoms, or late onset of the disease. </p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">GARS</italic>-associated axonal neuropathy may have the disorder as the result of a new gene mutation. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutations is unknown. </p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> mutation include neurologic exam, a nerve conduction study, and molecular genetic testing if a mutation has been identified in the proband. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs of the proband depends on the genetic status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%. </p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low but is greater than that of the general population because of the possibility of germline mosaicism. </p>
            </list-item>
            <list-item>
              <p>Although no instances of germline mosaicism have been reported, it remains a possibility. </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">GARS</italic>-associated axonal neuropathy is at a 50% risk of inheriting the mutation. </p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk. </p>
        </sec>
        <sec id="cmt2d.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has a disease-causing mutation and/or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. </p>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="cmt2d.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis usually performed at about 15 to 18 weeks&#x02019; gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks&#x02019; gestation. The disease-causing allele of an affected family member must be identified before prenatal testing can be performed.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutation has been identified. </p>
        </sec>
      </sec>
      <sec id="cmt2d.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cmt2d.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Benign allelic variants.</bold>
<italic toggle="yes">GARS</italic> spans 40 kb and contains 17 exons. The 2.7-kb <italic toggle="yes">GARS</italic> transcript is ubiquitously expressed. There are six known sequence variants: two (p.Ser252Leu and p.Gln334Arg) are nonsynonymous and four are synonymous. </p>
        <p><bold>Pathogenic allelic variants.</bold> The mutations are distributed throughout the protein in multiple functional domains. </p>
        <p>To date, 11 mutations in <italic toggle="yes">GARS</italic> have been reported: </p>
        <list list-type="bullet">
          <list-item>
            <p>The mutations p.Glu71Gly, p.Leu129Pro, and p.Gly240Arg, which segregate in pedigrees with LOD scores over 5, are the most tightly linked to the disease locus [<xref ref-type="bibr" rid="cmt2d.REF.christodoulou.1995.1629">Christodoulou et al 1995</xref>, <xref ref-type="bibr" rid="cmt2d.REF.ionasescu.1996.1373">Ionasescu et al 1996</xref>, <xref ref-type="bibr" rid="cmt2d.REF.sambuughin.1998.23">Sambuughin et al 1998</xref>, <xref ref-type="bibr" rid="cmt2d.REF.antonellis.2003.1293">Antonellis et al 2003</xref>]. </p>
          </list-item>
          <list-item>
            <p>Variants identified by sequencing <italic toggle="yes">GARS</italic> in small families and simplex cases (i.e., a single occurrence of axonal neuropathy in a family), p.Ala57Val, p.Pro244Leu, p.Ile280Phe, p.Asp500Asn, p.Gly526Arg, p.Ser581Leu, and p.Gly598Ala, are less clearly implicated [<xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al 2005</xref>, <xref ref-type="bibr" rid="cmt2d.REF.delbo.2006.752">Del Bo et al 2006</xref>, <xref ref-type="bibr" rid="cmt2d.REF.james.2006.1710">James et al 2006</xref>, <xref ref-type="bibr" rid="cmt2d.REF.rohkamm.2007.100">Rohkamm et al 2007</xref>, <xref ref-type="bibr" rid="cmt2d.REF.abe.2009.310">Abe &#x00026; Hayasaka 2009</xref>, <xref ref-type="bibr" rid="cmt2d.REF.hamaguchi.2010.1202">Hamaguchi et al 2010</xref>]. </p>
          </list-item>
        </list>
        <p>The variants p.Leu129Pro and p.His418Arg are associated exclusively with the dSMA-V clinical subtype; p.Gly240Arg, p.Ile280Phe, and p.Gly526Arg are associated with the CMT2D subtype. Families with the p.Glu71Gly, p.Pro244Leu, and p.Asp500Asn variants had both subtypes.</p>
        <p><bold>Normal gene product.</bold> Glycyl-tRNA synthetase, a class II aminoacyl-tRNA synthetase, performs an essential function in protein synthesis in the ribosome by catalyzing aminoacylation of glycyl-tRNA, which is required for charging tRNA with cognate amino acids [<xref ref-type="bibr" rid="cmt2d.REF.ge.1994.28790">Ge et al 1994</xref>]. The enzyme must properly recognize the tRNA species and the amino acid in order to maintain fidelity of translation. In accordance with its function, glycyl-tRNA synthetase contains three domains: a catalytic core, a C-terminal anticodon recognition domain, and a domain that interacts with the acceptor stem of glycyl-tRNA [<xref ref-type="bibr" rid="cmt2d.REF.freist.1996.343">Freist et al 1996</xref>]. Glycyl-tRNA synthetase is ubiquitously expressed and absolutely necessary for protein translation in all cells.</p>
        <p><bold>Abnormal gene product.</bold> Some of the reported mutations cause loss of function as assayed by in vitro aminoacylation or yeast viability. These results are consistent with a disease mechanism of haploinsufficiency in charging function. However, other mutations do not alter enzyme activity in these assays, suggesting more complicated disease mechanisms apparently associated with <italic toggle="yes">GARS</italic> functions. Since the discovery of glycyl-tRNA synthetase role in CMT2D, the challenge has been to determine how missense mutations in this critical and widely expressed protein cause selective degeneration of axons in peripheral nerves.</p>
        <p>Further research efforts are needed for identification of specific disease mechanisms affecting peripheral axons. </p>
      </sec>
      <sec id="cmt2d.References">
        <title>References</title>
        <sec id="cmt2d.Literature_Cited">
          <title>Literature Cited </title>
          <ref-list id="cmt2d.Literature_Cited.reflist0">
            <ref id="cmt2d.REF.abe.2009.310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayasaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy.</article-title>
                <source>J Hum Genet.</source>
                <year>2009</year>
                <volume>54</volume>
                <fpage>310</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19329989</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.antonellis.2003.1293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Antonellis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellsworth</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sambuughin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puls</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Lin</surname>
                    <given-names>SQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremensky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christodoulou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ionasescu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funalot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>ED</given-names>
                  </name>
                </person-group>
                <article-title>Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.</article-title>
                <source>Am J Hum Genet</source>
                <year>2003</year>
                <volume>72</volume>
                <fpage>1293</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12690580</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.christodoulou.1995.1629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Christodoulou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyriakides</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hristova</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Georgiou</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yshpekova</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanova</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton</surname>
                    <given-names>LT</given-names>
                  </name>
                </person-group>
                <article-title>Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p.</article-title>
                <source>Hum Mol Genet</source>
                <year>1995</year>
                <volume>4</volume>
                <fpage>1629</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">8541851</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.delbo.2006.752">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del Bo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locatelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghezzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagiolari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <article-title>Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation.</article-title>
                <source>Neurology</source>
                <year>2006</year>
                <volume>66</volume>
                <fpage>752</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16534118</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.dubourg.2006.1721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dubourg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzedine</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaou</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barois</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meininger</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouteiller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V.</article-title>
                <source>Neurology</source>
                <year>2006</year>
                <volume>66</volume>
                <fpage>1721</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16769947</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.ellsworth.1999.568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ellsworth</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ionasescu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Searby</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braden</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucaba</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPherson</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marra</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>ED</given-names>
                  </name>
                </person-group>
                <article-title>The CMT2D locus: refined genetic position and construction of a bacterial clone-based physical map.</article-title>
                <source>Genome Res</source>
                <year>1999</year>
                <volume>9</volume>
                <fpage>568</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">10400924</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.freist.1996.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freist</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Logan</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauss</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <article-title>Glycyl-tRNA synthetase.</article-title>
                <source>Biol Chem Hoppe Seyler</source>
                <year>1996</year>
                <volume>377</volume>
                <fpage>343</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">8839980</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.ge.1994.28790">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ge</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trieu</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Targoff</surname>
                    <given-names>IN</given-names>
                  </name>
                </person-group>
                <article-title>Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis.</article-title>
                <source>J Biol Chem</source>
                <year>1994</year>
                <volume>269</volume>
                <fpage>28790</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7961834</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.hamaguchi.2010.1202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamaguchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwasa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Charcot-Marie-Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation.</article-title>
                <source>J Neurol.</source>
                <year>2010</year>
                <volume>257</volume>
                <fpage>1202</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20169446</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.ionasescu.1996.1373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ionasescu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Searby</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roklina</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ionasescu</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D).</article-title>
                <source>Hum Mol Genet</source>
                <year>1996</year>
                <volume>5</volume>
                <fpage>1373</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8872480</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.irobi.2004a.R195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Irobi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Molecular genetics of distal hereditary motor neuropathies.</article-title>
                <source>Hum Mol Genet</source>
                <year>2004a</year>
                <volume>13</volume>
                <issue>Spec No 2</issue>
                <fpage>R195</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">15358725</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.irobi.2004b.2124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Irobi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Bergh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dierick</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpoorten</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Windpassinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerwen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V.</article-title>
                <source>Brain</source>
                <year>2004b</year>
                <volume>127</volume>
                <fpage>2124</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15242882</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.irobi.2004c.597">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Irobi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Impe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dierick</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpoorten</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerwen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vennekens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilton-Jones</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremensky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Bosch</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robberecht</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Vandekerckhove</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gettemans</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy.</article-title>
                <source>Nat Genet</source>
                <year>2004c</year>
                <volume>36</volume>
                <fpage>597</fpage>
                <lpage>601</lpage>
                <pub-id pub-id-type="pmid">15122253</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.james.2006.1710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cader</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Childs</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crow</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talbit</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene.</article-title>
                <source>Neurology</source>
                <year>2006</year>
                <volume>67</volume>
                <fpage>1710</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">17101916</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.motley.2010.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Motley</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>GARS axonopathy: not every neuron's cup of tRNA.</article-title>
                <source>Trends Neurosci.</source>
                <year>2010</year>
                <volume>33</volume>
                <fpage>59</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20152552</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.rohkamm.2007.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rohkamm</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotter-Weigel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barisic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laur&#x000e0;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miltenberger-Miltenyi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grill</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakeling</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieber</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome.</article-title>
                <source>J Neurol Sci.</source>
                <year>2007</year>
                <volume>263</volume>
                <fpage>100</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17663003</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.sambuughin.1998.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sambuughin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selenge</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedlich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baasanjav</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15.</article-title>
                <source>J Neurol Sci</source>
                <year>1998</year>
                <volume>161</volume>
                <fpage>23</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9879677</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.silver.1966.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <article-title>Familial spastic paraplegia with amyotrophy of the hands.</article-title>
                <source>Ann Hum Genet</source>
                <year>1966</year>
                <volume>30</volume>
                <fpage>69</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">5964029</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.sivakumar.2005.2304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyriakides</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puls</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funalot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonellis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sambuughin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christodoulou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zamba-Papanicolaou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ionasescu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalakas</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.</article-title>
                <source>Brain</source>
                <year>2005</year>
                <volume>128</volume>
                <fpage>2304</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16014653</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.windpassinger.2004.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Windpassinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irobi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horl</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dierick</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpoorten</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warner</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proukakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Bergh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crosby</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome.</article-title>
                <source>Nat Genet</source>
                <year>2004</year>
                <volume>36</volume>
                <fpage>271</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14981520</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cmt2d.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cmt2d.Suggested_Reading.reflist0">
            <ref id="cmt2d.REF.anderson.2003.595">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talbot</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.</article-title>
                <source>Curr Opin Neurol</source>
                <year>2003</year>
                <volume>16</volume>
                <fpage>595</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14501843</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.barisic.2008.416">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barisic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirotkovi&#x00107;-Skerlev</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;fgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Charcot-Marie-Tooth disease: a clinico-genetic confrontation.</article-title>
                <source>Ann Hum Genet.</source>
                <year>2008</year>
                <volume>72</volume>
                <fpage>416</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">18215208</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.dyck.1968a.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <article-title>Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: I. Neurologic, genetic and electrophysiologic findings in hereditary polyneuropathies.</article-title>
                <source>Arch Neurol</source>
                <year>1968a</year>
                <volume>18</volume>
                <fpage>603</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">4297451</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.dyck.1968b.619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <article-title>Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: II. Neurologic, genetic and electrophysiologic findings in various neuronal degenerations.</article-title>
                <source>Arch Neurol</source>
                <year>1968b</year>
                <volume>18</volume>
                <fpage>619</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">5652992</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.puls.2003.455">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puls</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonnakuty</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaMonte</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holzbaur</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floeter</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bidus</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drayna</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludlow</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Mutant dynactin in motor neuron disease.</article-title>
                <source>Nat Genet</source>
                <year>2003</year>
                <volume>33</volume>
                <fpage>455</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12627231</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2d.REF.zuchner.2004.449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zuchner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mersiyanova</surname>
                    <given-names>IV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bissar-Tadmouri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochelle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dadali</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zappia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patitucci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evgrafov</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonghe</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pericak-Vance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battaloglu</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polyakov</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.</article-title>
                <source>Nat Genet</source>
                <year>2004</year>
                <volume>36</volume>
                <fpage>449</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15064763</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cmt2d.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cmt2d.Acknowledgments">
          <title>Acknowledgments</title>
          <p>This work was supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health. </p>
        </sec>
        <sec id="cmt2d.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>25 August 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 January 2007 (lgg) Revision: sequence analysis clinically available for mutations in GARS</p>
            </list-item>
            <list-item>
              <p>8 November 2006 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>24 February 2006 (lgg) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="cmt2d.1.12" sec-type="figs-and-tables">
        <title/>
        <fig id="cmt2d.F1" position="float" orientation="portrait">
          <label>Figure 1.</label>
          <caption>
            <p>Sural nerve morphology in <italic toggle="yes">GARS</italic> mutation-related dSMA-V and CMT2D phenotypesA. dSMA-V. Pathologic changes are minimal with a near-normal myelinated nerve fiber density. B. CMT2D. Myelinated nerve fiber density is moderately reduced. C. CMT2D. Unmyelinated fiber cluster D. CMT2D. Active axonal degeneration of myelinated nerve fiber E. CMT2D. Multiple regenerative clusters (arrowheads)Reprinted from <xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al [2005]</xref> by permission of Oxford University Press</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmt2dFig1" position="anchor" orientation="portrait"/>
        </fig>
        <fig id="cmt2d.F2" position="float" orientation="portrait">
          <label>Figure 2.</label>
          <caption>
            <p>Distribution of muscle weakness and atrophy in individuals with two major clinical subtypes of <italic toggle="yes">GARS</italic> mutation associated diseaseA. Thenar and first dorsal interosseus muscle wasting with relatively preserved hypothenar in an individual with dSMA-V phenotype B. Peroneal atrophy, <italic toggle="yes">pes cavus</italic>, and hammerhead toes in an individual with the CMT2D clinical variant; this individual also has a reduction of pinprick, temperature, touch, and vibration sense in stocking distribution.Reprinted from <xref ref-type="bibr" rid="cmt2d.REF.sivakumar.2005.2304">Sivakumar et al [2005]</xref> by permission of Oxford University Press</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmt2dFig2" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
